WRAIX vs. BIVRX

Last updated Jun 3, 2026

WRAIX (Wilmington Global Alpha Equities Fund) and BIVRX (Invenomic Fund) are both Long-Short funds. Over the past 5 years, WRAIX returned 5.39%/yr vs 7.53%/yr for BIVRX. At a 0.05 correlation, their price movements are largely independent. WRAIX charges 1.24%/yr vs 2.48%/yr for BIVRX.

Performance

WRAIX vs. BIVRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Wilmington Global Alpha Equities Fund (WRAIX) and Invenomic Fund (BIVRX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, WRAIX achieves a 3.69% return, which is significantly higher than BIVRX's -9.39% return.

WRAIX

• 1D: -0.07%
• 1M: 1.64%
• YTD: 3.69%
• 6M: 4.16%
• 1Y: 8.07%
• 3Y*: 8.65%
• 5Y*: 5.39%
• 10Y*: 5.40%

BIVRX

• 1D: 3.01%
• 1M: -3.97%
• YTD: -9.39%
• 6M: -5.92%
• 1Y: -2.19%
• 3Y*: -3.13%
• 5Y*: 7.53%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

WRAIX vs. BIVRX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
WRAIX Wilmington Global Alpha Equities Fund	3.69%	9.13%	7.74%	7.73%	-3.41%	6.52%	1.04%	12.34%	-2.67%	3.87%
BIVRX Invenomic Fund	-9.39%	4.39%	-9.03%	16.47%	49.61%	44.06%	11.12%	11.36%	3.41%	8.73%

Correlation

The correlation between WRAIX and BIVRX is -0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.09
Correlation (3Y) Calculated over the trailing 3-year period	-0.09
Correlation (5Y) Calculated over the trailing 5-year period	-0.01
Correlation (All Time) Calculated using the full available price history since Jun 26, 2017	0.05

The correlation between WRAIX and BIVRX shifts across timeframes, from -0.09 (1 year) to 0.05 (all time), reflecting how their relationship changes across market environments.

Return for Risk

WRAIX vs. BIVRX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WRAIX

WRAIX Risk / Return Rank: 25
WRAIX Sharpe Ratio Rank: 23
WRAIX Sortino Ratio Rank: 23
WRAIX Omega Ratio Rank: 30
WRAIX Calmar Ratio Rank: 20
WRAIX Martin Ratio Rank: 29

BIVRX

BIVRX Risk / Return Rank: 2
BIVRX Sharpe Ratio Rank: 2
BIVRX Sortino Ratio Rank: 2
BIVRX Omega Ratio Rank: 2
BIVRX Calmar Ratio Rank: 2
BIVRX Martin Ratio Rank: 2

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WRAIX vs. BIVRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Wilmington Global Alpha Equities Fund (WRAIX) and Invenomic Fund (BIVRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	WRAIX	BIVRX	Difference
Sharpe ratio Return per unit of total volatility	1.40	-0.11	+1.51
Sortino ratio Return per unit of downside risk	2.05	0.00	+2.04
Omega ratio Gain probability vs. loss probability	1.29	1.00	+0.29
Calmar ratio Return relative to maximum drawdown	1.67	-0.16	+1.82
Martin ratio Return relative to average drawdown	7.03	-0.42	+7.45
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

WRAIX vs. BIVRX - Sharpe Ratio Comparison

The current WRAIX Sharpe Ratio is 1.40, which is higher than the BIVRX Sharpe Ratio of -0.11. The chart below compares the historical Sharpe Ratios of WRAIX and BIVRX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	WRAIX	BIVRX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.40	-0.11	+1.51
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.84	0.43	+0.40
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.80	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.69	0.75	-0.06

Drawdowns

WRAIX vs. BIVRX - Drawdown Comparison

The maximum WRAIX drawdown since its inception was -15.44%, smaller than the maximum BIVRX drawdown of -21.14%. Use the drawdown chart below to compare losses from any high point for WRAIX and BIVRX.

Drawdown Indicators

	WRAIX	BIVRX	Difference
Max Drawdown Largest peak-to-trough decline	-15.44%	-21.14%	+5.70%
Max Drawdown (1Y) Largest decline over 1 year	-5.03%	-20.70%	+15.67%
Max Drawdown (3Y) Largest decline over 3 years	-5.03%	-21.14%	+16.11%
Max Drawdown (5Y) Largest decline over 5 years	-9.24%	-21.14%	+11.90%
Max Drawdown (10Y) Largest decline over 10 years	-15.44%	—	—
Current Drawdown Current decline from peak	-0.07%	-15.49%	+15.42%
Average Drawdown Average peak-to-trough decline	-1.98%	-6.05%	+4.07%
Ulcer Index Depth and duration of drawdowns from previous peaks	1.19%	7.73%	-6.54%

Volatility

WRAIX vs. BIVRX - Volatility Comparison

The current volatility for Wilmington Global Alpha Equities Fund (WRAIX) is 1.48%, while Invenomic Fund (BIVRX) has a volatility of 11.30%. This indicates that WRAIX experiences smaller price fluctuations and is considered to be less risky than BIVRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	WRAIX	BIVRX	Difference
Volatility (1M) Calculated over the trailing 1-month period	1.48%	11.30%	-9.82%
Volatility (6M) Calculated over the trailing 6-month period	4.71%	19.69%	-14.98%
Volatility (1Y) Calculated over the trailing 1-year period	5.92%	23.84%	-17.92%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	6.47%	17.44%	-10.97%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	6.73%	17.50%	-10.77%

WRAIX vs. BIVRX - Expense Ratio Comparison

WRAIX has a 1.24% expense ratio, which is lower than BIVRX's 2.48% expense ratio.

Dividends

WRAIX vs. BIVRX - Dividend Comparison

WRAIX's dividend yield for the trailing twelve months is around 0.17%, less than BIVRX's 2.13% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BIVRX Invenomic Fund	2.13%	1.93%	3.55%	20.26%	28.43%	3.00%	3.11%	3.21%	4.82%	1.21%	0.00%	0.00%
WRAIX Wilmington Global Alpha Equities Fund	0.17%	0.17%	1.47%	1.31%	2.77%	0.52%	1.98%	1.15%	1.25%	1.15%	0.30%	2.38%

Frequently Asked Questions

Can I hold both WRAIX and BIVRX in my portfolio?

WRAIX and BIVRX have a correlation of -0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, WRAIX or BIVRX?

BIVRX has higher volatility (11.30%) compared to WRAIX (1.48%). In terms of maximum drawdown, WRAIX dropped -15.44% vs BIVRX's -21.14%.

Which has better risk-adjusted returns?

WRAIX currently has the higher Sharpe Ratio (1.40 vs -0.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.